🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if bempedoic acid (ETC-1002) 180m...
Status
Completed
Location
L-MARC Research Center
Start Date
2017-04-07
Trial ID
NCT03193047
Treatments Being Tested
The purpose of this study is to preliminarily observe the efficacy and safe...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-06
Trial ID
NCT06391905
Acute coronary syndrome (ACS) is a lethal disease, reduced low-density lipo...
Status
Unknown
Location
Tangzhiming Li
Start Date
2021-04-22
Trial ID
NCT04730648
Treatments Being Tested
The study is a prospective, open-label, randomized, single-center study inv...
Status
Completed
Location
Beijing Anzhen Hospital
Start Date
2019-03-02
Trial ID
NCT04851769
Treatments Being Tested
This study (EPOCH-TECT) was a single-center, randomized, open-label, blinde...
Status
Completed
Location
Affiliated Hospital of Xuzhou Medical University
Start Date
2025-12-20
Trial ID
NCT07295366
Treatments Being Tested
This is a randomized, controlled clinical trial based on prior exploratory ...
Status
Not Yet Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2027-01-01
Trial ID
NCT07686796
Treatments Being Tested
This is a first-in-human,randomized, double-blind, placebo-controlled, sing...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2018-05-23
Trial ID
NCT04169386
The primary objective was to evaluate the effect of 12 weeks of subcutaneou...
Status
Completed
Location
Research Site
Start Date
2013-01-24
Trial ID
NCT01763905
Treatments Being Tested
Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors increase LDL re...
Status
Unknown
Location
Eduard Ilgiyaev
Start Date
2019-01
Trial ID
NCT03634293
Treatments Being Tested
Aim 1: To determine whether therapy with Alirocumab, compared to pre-treatm...
Status
Unknown
Location
Westside Medical Associates of Los Angeles
Start Date
2016-11
Trial ID
NCT02992301
Treatments Being Tested